025620.Ks
The company operates in the Personal Products industry, manufacturing and selling personal care products to consumers, generating revenue primarily through product sales.
Business. The company operates in the Personal Products industry, manufacturing and selling personal care products to consumers, generating revenue primarily through product sales.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Personal Products industry, manufacturing and selling personal care products to consumers, generating revenue primarily through product sales.
The company's capital structure is characterized by a debt-to-equity ratio of 0.41, indicating a relatively conservative leverage position compared to the industry median of 0.55. However, the liquidity position is constrained, with negative net cash after subtracting total debt, and a current ratio of 1.49, which is below the industry median of 1.65. The price-to-book ratio of 1.82 suggests the market values the company at a premium to its book value, but the price-to-earnings ratio of 100.49 is significantly higher than the industry median of 15.2, reflecting a high valuation multiple despite negative operating income.
Profitability metrics show a return on equity of 1.81% and a return on assets of 1.24%, both of which are below the industry median of 5.7% and 4.1%, respectively. The company's operating margin is -10.2%, compared to an industry median of 12.3%, highlighting a significant underperformance in cost control and operational efficiency. The gross margin of 28.3% is also below the industry median of 35.6%, indicating challenges in maintaining pricing power or managing production costs.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdown in the financial data suggests a high concentration risk, as the company's performance is tied to a single market or product line.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year. The operating cash flow is negative at -6.7 billion KRW, and the free cash flow of 1.5 billion KRW is insufficient to cover capital expenditures of 620 million KRW. The absence of a clear growth strategy or expansion plans in the financial data raises concerns about the company's ability to sustain or increase revenue in the near term.
The risk assessment highlights a medium liquidity risk due to negative net cash and a current ratio below the industry median. The dilution risk is low, with no near-term pressure from share issuance or convertible debt. However, the company's negative operating income and high valuation multiple increase the risk of earnings volatility and potential downgrades in analyst estimates. The absence of a detailed risk management strategy in the financial data further exacerbates these risks.
Recent events include a significant drop in operating income to -7.5 billion KRW, driven by increased costs and lower sales. The company's free cash flow remains positive at 1.5 billion KRW, but this is insufficient to cover capital expenditures. The absence of recent filings or transcripts limits the visibility into management's strategic direction and operational improvements. The company's financial performance and risk profile suggest a need for closer monitoring of cost management and revenue diversification efforts.
- The company's high price-to-earnings ratio of 100.49 indicates a premium valuation despite negative operating income.
- The return on equity of 1.81% and return on assets of 1.24% are significantly below industry medians, highlighting poor profitability.
- The company's revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
- The liquidity position is constrained, with a current ratio of 1.49 and negative net cash after subtracting total debt.
- The absence of a clear growth strategy and recent earnings volatility raise concerns about the company's long-term sustainability.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 025620.KS Market data — financials · 2026-05-26
- Cha AI Healthkare Co Ltd Market data — analyst estimates · 2026-05-26